0035

KR:CO:YUNGJIN

영진약품주식회사

  • Stock

Last Close

2,080.00

22/11 06:30

Market Cap

398.71B

Beta: -

Volume Today

109.82K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
31.08B
-
31.89B
2.60%
32.00B
0.35%
38.61B
20.66%
42.40B
9.82%
44.26B
4.38%
51.90B
17.25%
53.70B
3.47%
45.54B
15.18%
44.06B
3.26%
24.23B
45.00%
average payables
11.21B
-
11.84B
5.60%
14.28B
20.67%
16.36B
14.53%
14.86B
9.17%
16.02B
7.82%
16.47B
2.84%
11.86B
27.98%
12.83B
8.16%
18.14B
41.37%
10.35B
42.94%
average receivables
41.95B
-
45.04B
7.37%
52.01B
15.49%
66.16B
27.20%
68.92B
4.17%
60.58B
12.10%
57.37B
5.30%
27.36B
52.31%
26.52B
-
26.52B
0%
book value per share
575.81
-
554.34
3.73%
563.46
1.65%
606.36
7.61%
640.62
5.65%
603.68
5.77%
644.35
6.74%
625.68
2.90%
570.50
8.82%
491.38
13.87%
capex per share
-37.80
-
-63.35
67.60%
-85.47
34.91%
-27.87
67.40%
-58.84
111.14%
-25.46
56.72%
-57.66
126.43%
-34.47
40.21%
-61.57
78.61%
-72.17
17.22%
capex to depreciation
-1.37
-
-2.34
70.62%
-2.60
10.86%
-0.84
67.79%
-1.66
98.89%
-0.71
57.42%
-1.35
91.13%
-0.81
40.18%
-1.53
89.33%
-1.70
10.58%
capex to operating cash flow
-1.13
-
-1.85
64.04%
-1.73
6.60%
-1.57
9.41%
-3.49
122.38%
-3.69
5.97%
-1.12
69.80%
-0.43
61.03%
-1.35
211.07%
1.14
184.05%
capex to revenue
-0.04
-
-0.07
60.09%
-0.09
30.20%
-0.03
71.77%
-0.06
123.06%
-0.03
55.18%
-0.05
85.99%
-0.03
35.61%
-0.06
90.90%
-0.06
4.70%
cash per share
50.60
-
17.06
66.29%
28.48
66.95%
10.91
61.70%
65.24
498.18%
-11.35
117.39%
-4.03
64.49%
-9.90
145.72%
-9.66
2.49%
3.73
138.64%
days of inventory on hand
120.48
-
106.00
12.02%
114.67
8.18%
132.12
15.22%
117.71
10.91%
139.71
18.69%
145.12
3.87%
139.07
4.17%
104.78
24.65%
115.13
9.88%
days payables outstanding
39.72
-
44.01
10.80%
54.50
23.81%
50.84
6.70%
36.84
27.54%
56.37
53.02%
35.38
37.24%
27.26
22.96%
41.17
51.02%
49.17
19.45%
days sales outstanding
97.12
-
105.43
8.55%
119.29
13.14%
144.96
21.52%
114.45
21.05%
117.52
2.68%
90.58
22.93%
88.67
-
debt to assets
0.12
-
0.11
12.14%
0.14
31.75%
0.11
18.57%
0.09
21.34%
0.06
29.64%
0.07
16.44%
0.04
46.95%
0.07
73.78%
0.19
187.77%
debt to equity
0.20
-
0.19
5.62%
0.27
43.11%
0.21
20.73%
0.15
28.63%
0.11
27.43%
0.13
14.75%
0.06
49.64%
0.12
95.64%
0.44
251.40%
dividend yield
earnings yield
0.04
-
0.00
90.25%
0.01
132.82%
0.00
69.18%
0.00
59.58%
-0.01
600.00%
0.00
176.02%
-0.00
102.14%
-0.01
13,054.97%
-0.03
190.15%
enterprise value
310.79B
-
255.02B
17.94%
402.04B
57.65%
1.55T
285.40%
1.69T
9.39%
1.11T
34.59%
1.20T
8.69%
1.48T
22.60%
985.15B
33.31%
674.19B
31.56%
enterprise value over ebitda
16.58
-
21.19
27.75%
36.31
71.36%
134.23
269.72%
166.75
24.22%
211.20
26.66%
67.61
67.99%
174.32
157.84%
-153.69
188.16%
-49.31
67.91%
ev to operating cash flow
52.20
-
41.03
21.41%
45.68
11.34%
497.91
990.03%
537.77
8.01%
870.07
61.79%
129.81
85.08%
101.90
21.50%
117.73
15.54%
-58.07
149.33%
ev to sales
1.98
-
1.52
23.30%
2.36
55.21%
8.02
239.64%
8.69
8.34%
5.95
31.57%
5.46
8.12%
7.09
29.69%
5.02
29.10%
3.09
38.56%
free cash flow per share
-4.34
-
-29.17
572.38%
-36.09
23.74%
-10.09
72.03%
-41.96
315.75%
-18.57
55.74%
-5.99
67.77%
44.80
848.43%
-16.06
135.84%
-135.65
744.83%
free cash flow yield
-0.00
-
-0.02
765.60%
-0.02
24.19%
-0.00
93.18%
-0.00
303.28%
-0.00
32.94%
-0.00
71.13%
0.01
717.18%
-0.00
154.48%
-0.04
1,186.09%
graham net net
-57.28
-
-128.31
124.01%
-167.91
30.86%
-66.77
60.23%
-31.09
53.43%
-95.61
207.48%
-91.29
4.52%
-272.08
198.05%
-387.05
42.25%
-265.25
31.47%
graham number
924.71
-
249.73
72.99%
490.79
96.53%
572.22
16.59%
379.66
33.65%
669.50
76.34%
637.13
4.83%
101.23
84.11%
899.27
788.38%
1.15K
28.13%
income quality
0.51
-
6.84
1,248.61%
2.60
61.99%
0.74
71.51%
1.69
127.87%
-0.21
112.38%
1.85
983.64%
-108.91
6,001.22%
-0.72
99.34%
0.53
173.17%
intangibles to total assets
0.01
-
0.01
6.38%
0.01
18.74%
0.01
7.47%
0.04
236.86%
0.01
68.80%
0.01
7.43%
0.01
24.64%
0.01
10.71%
0.01
77.59%
0
100%
interest coverage
5.83
-
10.56
81.21%
5.80
45.03%
6.93
19.36%
6.54
5.55%
-8.02
222.65%
2.74
-
-66.41
2,521.58%
-10.00
84.95%
interest debt per share
121.02
-
107.53
11.15%
156.02
45.09%
133.43
14.48%
99.70
25.28%
67.96
31.83%
81.43
19.82%
41.21
49.40%
72.17
75.15%
219.02
203.48%
inventory turnover
3.03
-
3.44
13.67%
3.18
7.56%
2.76
13.21%
3.10
12.24%
2.61
15.75%
2.52
3.73%
2.62
4.35%
3.48
32.72%
3.17
8.99%
invested capital
0.20
-
0.19
5.62%
0.27
43.11%
0.21
20.73%
0.15
28.63%
0.11
27.43%
0.13
14.75%
0.06
49.64%
0.12
95.64%
0.44
251.40%
market cap
298.90B
-
237.27B
20.62%
379.62B
59.99%
1.53T
302.65%
1.68T
9.97%
1.10T
34.67%
1.19T
8.45%
1.47T
23.46%
972.56B
33.86%
635.55B
34.65%
net current asset value
16.67B
-
4.22B
74.68%
533.44M
87.36%
29.54B
5,438.32%
29.82B
0.94%
25.18B
15.58%
26.64B
5.80%
25.01B
6.12%
478.24M
98.09%
-11.02B
2,403.90%
net debt to ebitda
0.63
-
1.47
132.36%
2.02
37.25%
1.81
10.52%
1.37
24.09%
1.99
44.93%
0.78
60.64%
0.81
3.15%
-1.96
342.90%
-2.83
43.84%
net income per share
66.00
-
5
92.42%
19.00
280.00%
24.00
26.32%
10
58.33%
-33.00
430.00%
28.00
184.85%
-0.73
102.60%
-63.00
8,555.45%
-120.08
90.60%
operating cash flow per share
33.46
-
34.19
2.17%
49.38
44.44%
17.77
64.01%
16.88
5.05%
6.89
59.16%
51.67
649.75%
79.27
53.40%
45.51
42.58%
-63.48
239.47%
payables turnover
9.19
-
8.29
9.75%
6.70
19.23%
7.18
7.18%
9.91
38.01%
6.47
34.65%
10.32
59.33%
13.39
29.80%
8.87
33.78%
7.42
16.28%
receivables turnover
3.76
-
3.46
7.88%
3.06
11.62%
2.52
17.71%
3.19
26.65%
3.11
2.61%
4.03
29.75%
4.12
-
research and ddevelopement to revenue
0.05
-
0.06
1.33%
0.07
24.70%
0.07
5.34%
0.07
8.97%
0.06
9.97%
0.06
4.72%
0.07
18.00%
0.07
6.47%
0.07
2.76%
return on tangible assets
0.07
-
0.01
92.68%
0.02
244.85%
0.02
20.46%
0.01
55.32%
-0.03
430.49%
0.03
180.59%
-0.00
102.81%
-0.06
8,324.40%
-0.11
82.27%
-0.02
78.61%
revenue per share
880.33
-
921.63
4.69%
954.98
3.62%
1.10K
15.51%
1.04K
5.34%
1.01K
3.43%
1.23K
21.75%
1.14K
7.15%
1.07K
6.44%
1.19K
11.96%
roe
0.11
-
0.01
92.13%
0.03
273.85%
0.04
17.38%
0.02
60.56%
-0.05
450.19%
0.04
179.49%
-0.00
102.68%
-0.11
9,392.59%
-0.24
121.28%
-0.06
75.75%
roic
0.06
-
0.01
86.32%
0.03
259.65%
0.03
13.37%
0.01
55.97%
-0.02
209.99%
0.04
351.38%
-0.00
107.68%
-0.09
2,935.70%
-0.05
42.51%
0.05
186.39%
sales general and administrative to revenue
0.03
-
0.03
2.16%
0.03
1.33%
0.03
1.95%
0.03
5.50%
0.03
1.65%
0.02
13.88%
0.02
7.11%
0.02
6.74%
0.01
38.97%
shareholders equity per share
575.81
-
554.34
3.73%
563.46
1.65%
606.36
7.61%
640.62
5.65%
603.68
5.77%
644.35
6.74%
625.68
2.90%
570.50
8.82%
491.38
13.87%
stock based compensation to revenue
tangible asset value
100.58B
-
98.94B
1.63%
98.05B
0.90%
103.91B
5.97%
111.86B
7.65%
109.27B
2.32%
113.54B
3.91%
112.87B
0.59%
103.44B
8.35%
87.19B
15.71%
226.60B
159.89%
tangible book value per share
565.31
-
544.17
3.74%
550.13
1.10%
593.44
7.87%
598.90
0.92%
591.03
1.32%
632.03
6.94%
617.12
2.36%
562.66
8.83%
476.73
15.27%
working capital
44.16B
-
39.45B
10.67%
51.58B
30.76%
79.81B
54.72%
76.55B
4.09%
71.58B
6.49%
71.54B
0.05%
68.53B
4.21%
41.36B
39.65%
52.56B
27.09%

All numbers in (except ratios and percentages)